Phibro Animal Health | PAHC - Koszty Sprzedaży





Koszty Sprzedaży Zmiana Data
Align Technology USD 298.76M 4.74M 2026-06
ANI Pharmaceuticals USD 119.8M 5.3M 2026-06
Aurora Cannabis CAD 8.22M 80.38M 2026-03
Bristol-Myers Squibb USD 7.89B 4.03B 2026-06
Canopy Growth CAD 62.98M 9.91M 2026-03
Corcept Therapeutics USD 4.06M 1.18M 2026-06
Eli Lilly USD 3.27B 309M 2026-06
Henry Schein USD 2.43B 129M 2026-06
Idexx Laboratories USD 437.5M 19.42M 2026-06
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Merck USD 3.14B 200M 2026-06
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Pacira USD 58.49M 7.75M 2026-06
Phibro Animal Health USD 240.42M 2.58M 2025-12
Prestige Brands USD 135.22M 5.54M 2026-06
Supernus Pharmaceuticals USD 59M 9.97M 2026-06
Zoetis USD 704M 32M 2026-06